Structure Therapeutics Inc.
Structure Therapeutics Inc. (GPCR) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · GPCR · as of Jun 8, 2026
Key Statistics
Explore Structure Therapeutics Inc. Data
gpcr stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 14 · Buy rate: 100.0%
The GPCR analyst consensus is Buy, based on ratings from 14 Wall Street analysts over the past 3 months. The average 12-month price target is $114.75, representing +205.84% upside from the current price of $37.52.
Competitors & Peers
gpcr competitorsGPCR
ABCL
CLDX
EWTX
GLPG
LQDAStock Performance
Full HistoryAbout Structure Therapeutics Inc.
Structure Therapeutics Inc. a clinical stage global biopharmaceutical company, develops and delivers novel oral therapeutics to treat a range of chronic diseases with unmet medical needs. Its lead pr…
what is structure therapeutics inc. · gpcr stock overview · structure therapeutics inc. company profile · who is structure therapeutics inc. ceo · gpcr NASDAQ · structure therapeutics inc. headquarters · structure therapeutics inc. business segments
About Stock Overview & Key Data
Structure Therapeutics Inc. (GPCR) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Feb 3, 2023. As of the latest trading session, GPCR stock price is $37.52, with a market capitalization of $2.2B. The stock has returned +82.94% over the past 12 months and -46.05% year-to-date.
According to 14 Wall Street analysts, the consensus rating for Structure Therapeutics Inc. stock is Buy, with an average 12-month price target of $114.75. In fiscal year 2025, Structure Therapeutics Inc. reported revenue of — and net income of -$141.2M. For detailed data — including Structure Therapeutics Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Structure Therapeutics Inc. (GPCR) stock price is $37.52. The stock is traded on NASDAQ under the ticker symbol GPCR. The 52-week range is $15.80 – $94.90.